It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Biocatalysis has been widely employed for the generation of carbon-carbon/heteroatom stereocentres, yet its application in chiral C(sp3)–S bond construction is rare and limited to enzymatic kinetic resolutions. Herein, we describe the enantioselective construction of chiral C(sp3)–S bonds through ene-reductase biocatalyzed conjugate reduction of prochiral vinyl sulfides. A series of cooperative sequential/concurrent chemoenzymatic and biocatalytic cascades have been developed to access a broad range of chiral sulfides, including valuable β-hydroxysulfides bearing two adjacent C(sp3)–S and C(sp3)–O stereocentres, in a stereoconvergent manner with good to excellent yields (up to 96%) and enantioselectivities (up to >99% ee). Notably, this biocatalytic strategy allows to overcome the long-standing shortcomings of catalyst poisoning and C(sp2)/C(sp3)–S bond cleavage faced in transition-metal-catalyzed hydrogenation of vinyl sulfides. Finally, the potential of this methodology is also exemplified by its broader application in the stereoconvergent assembly of chiral C(sp3)–N/O/Se bonds with good to excellent enantioselctivities.
Biocatalysis has been widely employed for the generation of carbon-carbon/heteroatom stereocenters, yet its application in chiral C(sp3)–S bond construction is rare. Herein, the authors describe the enantioselective construction of chiral C(sp3)–S bonds through ene-reductase biocatalysed conjugate reduction of prochiral vinyl sulfides.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Mattana, Ariane 1 ; Alam, Ruqaiya 1
; Montgomery, Sarah L. 2
; Pandya, Akash 2 ; Manetti, Fabrizio 3
; Dominguez, Beatriz 2 ; Castagnolo, Daniele 1
1 University College London, Department of Chemistry, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201)
2 Johnson Matthey, Cambridge, UK (GRID:grid.13515.33) (ISNI:0000 0001 0679 3687)
3 University of Siena, Department of Biotechnology, Chemistry and Pharmacy, Siena, Italy (GRID:grid.9024.f) (ISNI:0000 0004 1757 4641)




